Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 603,094 483,107 525,081 502,890 700,001 511,606 - -
Change - -19.9% 8.69% -4.23% 39.2% -26.91% - -
Enterprise Value (EV) 1 553,560 450,132 497,354 477,918 692,920 491,326 486,005 483,277
Change - -18.68% 10.49% -3.91% 44.99% -29.09% -1.08% -0.56%
P/E 22.2x 20.9x 22.1x 20.6x 22.6x 14.9x 16.4x 15.1x
PBR 3.54x 2.54x 2.49x 2.17x 2.72x 1.68x 1.66x 1.52x
PEG - -1.4x 7.98x 7.61x 0.8x 4.32x -8.69x 1.81x
Capitalization / Revenue 0.83x 0.64x 0.63x 0.52x 0.69x 0.43x 0.43x 0.4x
EV / Revenue 0.76x 0.6x 0.6x 0.5x 0.69x 0.45x 0.41x 0.38x
EV / EBITDA 11.8x 10x 10.5x 9.29x 11.1x 7.4x 6.93x 6.46x
EV / EBIT 16.7x 15.1x 16.5x 15.2x 17.1x 11.7x 11x 10.4x
EV / FCF 65.2x -39.1x 93.5x -222x -807x 113x 131x 630x
FCF Yield 1.53% -2.56% 1.07% -0.45% -0.12% -4.85% 0.76% 0.16%
Dividend per Share 2 35 40 50 60 70 82 84.2 89.51
Rate of return 0.46% 0.66% 0.75% 0.95% 0.79% 1.36% 1.3% 1.39%
EPS 2 342.9 292.4 300.5 308.6 390.9 404.3 394.5 427.5
Distribution rate 10.2% 13.7% 16.6% 19.4% 17.9% 20.3% 21.3% 20.9%
Net sales 1 726,424 755,414 827,697 964,989 1,011,390 1,099,583 1,190,218 1,273,178
EBITDA 1 46,932 44,906 47,496 51,425 62,633 66,929 70,103 74,852
EBIT 1 33,147 29,796 30,128 31,501 40,404 42,353 44,041 46,529
Net income 1 27,156 23,155 23,797 24,454 30,978 32,046 31,371 33,890
Net Debt 1 -49,534 -32,975 -27,727 -24,972 -7,081 -20,280 -25,601 -28,329
Reference price 2 7,615.00 6,100.00 6,630.00 6,345.00 8,832.00 6,455.00 6,455.00 6,455.00
Nbr of stocks (in thousands) 79,198 79,198 79,198 79,258 79,257 79,257 - -
Announcement Date 12/7/21 11/7/22 10/7/23 12/7/24 11/7/25 13/7/26 - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.73x0.44x7.24x1.2% 3.16B
23.46x0.4x6.17x2.04% 6.84B
15.36x0.43x6.35x1.37% 3.15B
12.77x0.45x5.58x3.75% 2.72B
20.96x0.79x11.12x1.44% 2.38B
14.55x0.43x4.1x3.48% 1.39B
16.61x0.48x6.59x4.29% 346M
Average 17.06x 0.49x 6.74x 2.51% 2.86B
Weighted average by Cap. 18.47x 0.47x 6.74x 2.1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation COSMOS Pharmaceutical Corporation